Business Context and Reporting Period
Company: Chemed Corporation (CHEMED)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2007
Business Overview: Chemed operates through two primary segments: VITAS Healthcare (hospice care services) and Roto-Rooter Group (plumbing and drain cleaning services). The company serves terminally ill patients and residential/commercial customers across the United States.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2007 |
|---|---|---|
| Service Revenues and Sales | $272,503 | $814,329 |
| Income from Continuing Operations | $16,916 | $42,570 |
| Net Income | $18,117 | $43,771 |
| Diluted EPS (Continuing Ops) | $0.69 | $1.69 |
| Diluted EPS (Net Income) | $0.74 | $1.73 |
| Cash Provided by Operating Activities | N/A | $90,143 |
| Cash and Cash Equivalents (End of Period) | $16,730 | $16,730 |
| Total Debt (Current + Long-Term) | $234,896 | $234,896 |
| Unused Revolving Credit Facility | $144.9 million | $144.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 7.4% for the quarter and 9.1% for the nine-month period compared to 2006. VITAS revenue grew 7.5% (quarter) and 8.8% (nine months), driven by a 4.6% increase in Average Daily Census (ADC) and Medicare rate increases. Roto-Rooter revenue grew 7.2% (quarter) and 9.5% (nine months), driven by price increases and job mix changes.
- Profitability: Income from continuing operations rose 31.4% for the quarter and 10.7% for the nine-month period. Gross margins improved to 29.2% (quarter) and 30.0% (nine months) from 26.9% and 27.6% in the prior year, respectively.
- Debt Restructuring: In May 2007, the company refinanced its credit facility, redeemed $150 million of Senior Notes, and issued $200 million of 1.875% Senior Convertible Notes due 2014. This resulted in a $13.8 million loss on extinguishment of debt for the nine-month period.
- Share Repurchases: The company repurchased 2.1 million shares of treasury stock for $130.9 million during the nine months ended September 30, 2007.
- Discontinued Operations: The company recorded a $1.2 million gain from discontinued operations (VITAS Phoenix program) in 2007, compared to a $5.4 million loss in the same period of 2006.
Guidance, Outlook, Risks, and Unusual Items
- Medicare Cap Liability: The company received notification regarding 2006 Medicare cap liabilities, revealing an over-accrual of $1.2 million. No revenue reduction was recorded for the 2007 measurement period as of the filing date.
- Convertible Notes: The $200 million convertible notes issued in May 2007 have a conversion price of approximately $80.73 per share. Dilution will occur if the stock price exceeds this threshold, though purchased call options are expected to offset some dilution.
- Litigation Risks:
- Wage and Hour Lawsuits: VITAS faces class action lawsuits in California regarding overtime and meal/rest periods. A $19.9 million settlement was approved in 2006 for one case; a second case is in early stages with unestimable liability.
- OIG Investigation: The Office of Inspector General is investigating VITAS' billing practices. A related qui tam complaint was dismissed with prejudice in July 2007, though plaintiffs are appealing. The company cannot predict the outcome or financial impact.
- Unusual Items: The nine-month results included a $1.1 million gain on the sale of a Florida call center building and significant costs related to debt extinguishment and long-term incentive compensation awards.
Investor Verification Checklist
- Verify the impact of the $200 million convertible note issuance on future diluted earnings per share, specifically monitoring the stock price relative to the $80.73 conversion price.
- Monitor the status of the OIG investigation and the pending appeal of the qui tam dismissal for potential future liabilities.
- Review the progress of the California wage and hour class action lawsuits and any potential settlement costs beyond the previously approved $19.9 million.
- Assess the sustainability of the improved gross margins, particularly the reduction in Medicare cap billing limitations compared to the prior year.
- Confirm the company's ability to maintain compliance with debt covenants under the new 2007 credit facility and convertible note indenture.